Your browser doesn't support javascript.
loading
Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells.
Taipaleenmäki, Hanna; Farina, Nicholas H; van Wijnen, Andre J; Stein, Janet L; Hesse, Eric; Stein, Gary S; Lian, Jane B.
Afiliação
  • Taipaleenmäki H; Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA, USA.
  • Farina NH; Heisenberg-Group for Molecular Skeletal Biology, Department of Trauma, Hand & Reconstructive Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • van Wijnen AJ; Department of Biochemistry & Cancer Center, University of Vermont College of Medicine, Burlington, VT, USA.
  • Stein JL; Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA, USA.
  • Hesse E; Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
  • Stein GS; Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA, USA.
  • Lian JB; Department of Biochemistry & Cancer Center, University of Vermont College of Medicine, Burlington, VT, USA.
Oncotarget ; 7(48): 79032-79046, 2016 Nov 29.
Article em En | MEDLINE | ID: mdl-27738322
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article